|
(2Z)-2-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-7,8-dimethyl[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one |
|
Pseudomonas Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother
|
|
(5R,6R)-5,6-bis[(4-benzyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
H
N
H
2
N
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-cyclohexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
N
H
NH
2
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-cyclopropyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
H
2
N
N
H
N
N
N
N
H
H
N
N
N
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
5beta,6alpha-Bis(4-heptyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
H
3
C
N
N
N
HN
H
2
N
N
N
N
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-hexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
H
3
C
N
N
N
N
H
H
2
N
N
N
N
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-pentyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
N
H
3
C
N
HN
H
2
N
N
N
N
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-phenyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
N
H
NH
2
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
(5R,6R)-5,6-bis[[4-(2-phenylethyl)triazol-1-yl]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
NH
N
H
N
NH
2
|
Acinetobacter Pseudomonas Staphylococcus |
Biofilm Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
(5R,6R)-5,6-bis[[4-(3-methylbutyl)triazol-1-yl]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
N
H
3
C
CH
3
N
N
H
H
2
N
N
N
N
CH
3
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
| | |